نتائج البحث

180P Schwann cells promotes tumour progression in small cell lung cancer.

• Authors : Cao, S.¹ (AUTHOR); Zhong, H.² (AUTHOR); Zhou, Y.¹ (AUTHOR)

Subjects: *SMALL cell lung cancer; *SCHWANN cells; *TUMORS

• Source: Annals of Oncology. 2022 Supplement 2, Vol. 33, pS113-S114. 2p.

تفاصيل العنوان

73P A novel nomogram for predicting hyperprogressive disease after immune checkpoint inhibitor treatment in lung cancer.

• Authors : Cao, S.¹ (AUTHOR); Zhong, H.² (AUTHOR)

Subjects: *IMMUNE checkpoint inhibitors; *LUNG cancer; *CANCER treatment

• Source: Annals of Oncology. 2022 Supplement 2, Vol. 33, pS64-S64. 1p.

تفاصيل العنوان

Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.

• Authors : Suenaga, M.¹; Schirripa, M.¹; Cao, S.²

Subjects: *COLON cancer patients; *GENETIC polymorphisms; *CELL cycle

• Source: Annals of Oncology. May2017, Vol. 28 Issue 5, p1015-1022. 8p. 1 Diagram, 1 Chart, 1 Graph.

تفاصيل العنوان

Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials.

• Authors : Sunakawa, Y.^1,2 ; Stintzing, S.³; Cao, S.

Subjects: *GENETIC regulation; *MACROPHAGES; *HEALTH outcome assessment

• Source: Annals of Oncology. Dec2015, Vol. 26 Issue 12, p2450-2456. 7p. 2 Charts, 1 Graph.

تفاصيل العنوان

Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer.

• Authors : Sunakawa, Y.¹ (AUTHOR); Stremitzer, S.¹ (AUTHOR); Cao, S.² (AUTHOR)

• Source: Annals of Oncology. Feb2015, Vol. 26 Issue 2, p307-314. 8p. 2 Charts, 1 Graph.

تفاصيل العنوان

483PA biomarker study to validate predictors for clinical outcome of cetuximab based chemotherapy in first-line metastatic colorectal cancer (mCRC) patients: JACCRO CC-05/06AR and FIRE-3.

• Authors : Sunakawa, Y¹ (AUTHOR); Stintzing, S² (AUTHOR); Cao, S³ (AUTHOR)

Subjects: *COLORECTAL cancer; *METASTASIS; *CANCER chemotherapy

• Source: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.

تفاصيل العنوان

Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials.

• Authors : Berger, M. D.¹; Stintzing, S.²; Heinemann, V.²

Subjects: *COLON cancer; *COLON cancer patients; *BEVACIZUMAB

• Source: Annals of Oncology. Nov2017, Vol. 28 Issue 11, p2780-2785. 6p. 1 Chart, 1 Graph.

تفاصيل العنوان

169P Urine tumor DNA fragmentation profiles provided a novel biomarker for early detection of prostate cancer.

• Authors : Xing, N.¹ (AUTHOR); Han, S.¹ (AUTHOR); Hu, L.² (AUTHOR)

Subjects: *EARLY detection of cancer; *PROSTATE cancer; *URINE

• Source: Annals of Oncology. Nov2022 Suppl 9, Vol. 33, pS1500-S1500. 1p.

تفاصيل العنوان

108P A comprehensive pan-cancer study of fusions in Chinese cancer patients.

• Authors : Li, M.¹ (AUTHOR); Zhang, Y.¹ (AUTHOR); Liang, X.¹ (AUTHOR)

Subjects: *CANCER patients; *CHINA studies

• Source: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS402-S403. 2p.

تفاصيل العنوان

383P A mass spectrometry-based assay for molecular profiling of gliomas and its validation on real-world clinical samples.

• Authors : Wang, T.¹ (AUTHOR); Tao, F.² (AUTHOR); Li, X.² (AUTHOR)

Subjects: *GLIOMAS

• Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS404-S405. 2p.

تفاصيل العنوان